ANVS US Equity
Annovis Bio, Inc.Health Care · Pharmaceutical Preparations · CIK 1477845 · FY ends Dec 31$1.85
+0.05 (+2.78%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 5.2M |
| % of shares out | 12.2% |
| Days to cover | 9.4 |
| Δ vs 2026-07-15 | -4.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 5,193,076 | -4.7% | 549,684 | 9.4 |
| 2026-07-15 | 5,450,385 | +12.1% | 1,079,470 | 5.0 |
| 2026-06-30 | 4,864,454 | +1.2% | 908,320 | 5.4 |
| 2026-06-15 | 4,804,638 | -4.3% | 1,188,765 | 4.0 |
| 2026-05-29 | 5,021,073 | +7.4% | 1,602,998 | 3.1 |
| 2026-05-15 | 4,674,614 | -3.0% | 964,619 | 4.8 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
